Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1988 2
1990 1
1992 2
1993 2
1994 5
1995 9
1996 8
1997 9
1998 6
1999 3
2000 5
2001 6
2002 9
2003 8
2004 11
2005 10
2006 15
2007 25
2008 28
2009 27
2010 33
2011 29
2012 34
2013 41
2014 25
2015 41
2016 36
2017 39
2018 64
2019 89
2020 78
2021 85
2022 93
2023 94
2024 37

Text availability

Article attribute

Article type

Publication date

Search Results

912 results

Results by year

Filters applied: . Clear all
Page 1
DDX3X: structure, physiologic functions and cancer.
Mo J, Liang H, Su C, Li P, Chen J, Zhang B. Mo J, et al. Among authors: su c. Mol Cancer. 2021 Feb 24;20(1):38. doi: 10.1186/s12943-021-01325-7. Mol Cancer. 2021. PMID: 33627125 Free PMC article. Review.
Immunoglobulin M perception by FcμR.
Li Y, Shen H, Zhang R, Ji C, Wang Y, Su C, Xiao J. Li Y, et al. Among authors: su c. Nature. 2023 Mar;615(7954):907-912. doi: 10.1038/s41586-023-05835-w. Epub 2023 Mar 22. Nature. 2023. PMID: 36949194
The nonautophagic functions of autophagy-related proteins.
Shang JN, Yu CG, Li R, Xi Y, Jian YJ, Xu N, Chen S. Shang JN, et al. Among authors: chen s. Autophagy. 2023 Sep 8:1-15. doi: 10.1080/15548627.2023.2254664. Online ahead of print. Autophagy. 2023. PMID: 37682088 Review.
Efficacy and Safety of ABBV-3373, a Novel Anti-Tumor Necrosis Factor Glucocorticoid Receptor Modulator Antibody-Drug Conjugate, in Adults with Moderate-to-Severe Rheumatoid Arthritis Despite Methotrexate Therapy: A Randomized, Double-Blind, Active-Controlled Proof-of-Concept Phase IIa Trial.
Buttgereit F, Aelion J, Rojkovich B, Zubrzycka-Sienkiewicz A, Chen S, Yang Y, Arikan D, D'Cunha R, Pang Y, Kupper H, Radstake T, Amital H. Buttgereit F, et al. Among authors: chen s. Arthritis Rheumatol. 2023 Jun;75(6):879-889. doi: 10.1002/art.42415. Epub 2023 Apr 2. Arthritis Rheumatol. 2023. PMID: 36512671 Clinical Trial.
Efficacy and Safety of Upadacitinib Monotherapy in Methotrexate-Naive Patients With Moderately-to-Severely Active Rheumatoid Arthritis (SELECT-EARLY): A Multicenter, Multi-Country, Randomized, Double-Blind, Active Comparator-Controlled Trial.
van Vollenhoven R, Takeuchi T, Pangan AL, Friedman A, Mohamed MF, Chen S, Rischmueller M, Blanco R, Xavier RM, Strand V. van Vollenhoven R, et al. Among authors: chen s. Arthritis Rheumatol. 2020 Oct;72(10):1607-1620. doi: 10.1002/art.41384. Epub 2020 Sep 8. Arthritis Rheumatol. 2020. PMID: 32638504 Free PMC article. Clinical Trial.
Efficacy and safety of upadacitinib maintenance therapy for moderately to severely active ulcerative colitis in patients responding to 8 week induction therapy (U-ACHIEVE Maintenance): overall results from the randomised, placebo-controlled, double-blind, phase 3 maintenance study.
Vermeire S, Danese S, Zhou W, Ilo D, Klaff J, Levy G, Yao X, Chen S, Sanchez Gonzalez Y, Hébuterne X, Lindsay JO, Higgins PDR, Cao Q, Nakase H, Colombel JF, Loftus EV Jr, Panaccione R. Vermeire S, et al. Among authors: chen s. Lancet Gastroenterol Hepatol. 2023 Nov;8(11):976-989. doi: 10.1016/S2468-1253(23)00208-X. Epub 2023 Sep 9. Lancet Gastroenterol Hepatol. 2023. PMID: 37683686
912 results